期刊文献+

高频超声评价阿霉素造模大鼠心功能的实验研究 被引量:6

Experimental study of high frequency echocardiography in evaluation of left ventricular function produced by adriamycin in rats
在线阅读 下载PDF
导出
摘要 目的评价高频超声心动图在阿霉素(ADM)造模大鼠心力衰竭研究中的价值。方法 30只SD大鼠随机分成对照组、ADM组。大鼠尾静脉注射ADM制成心力衰竭模型。对两组大鼠行经胸高频超声心动图监测。分别取两组大鼠的心肌组织行HE染色及VG染色。结果高频超声心动图可以清晰显示大鼠的心脏结构,经超声测定ADM组与对照组心功能变化比较差异有统计学意义(P<0.01)。经高频超声心动图所证实的心力衰竭大鼠,HE染色及VG染色结果均证实其心肌组织明显受损。结论经胸高频超声心动图可以无创、准确地评价ADM造模大鼠心功能的改变,与病理结果一致。 Objective To assess the effect of high frequency echocardiography on cardiac failure of rats produced by adriamycin (ADM, doxorubicin). Methods 30 SD rats were randomly divided into control group and ADM group. The model of cardiac failure of rats was made by injecting ADM into their tail veins. Then we observed two groups of rats with high frequency echocardiography. The myocardiac tissue of rats was observed by HE staining and VG staining method. Results High frequency echocardiography could reveal vividly the structure of rats' hearts. There was statistical significance between the normal control group and the ADM group in the changes of heart function which was concluded by high frequency echocardiography (P 〈 0.01 ). The results of HE staining and VG staining of rats' myocardiac tissue also proved that there was obviously injury. Conclusion High frequency echocardiography is an accurate and noinvasive method in assessing the changes of heart function of rats, and it is in according with phathology.
出处 《安徽医科大学学报》 CAS 北大核心 2012年第1期20-23,共4页 Acta Universitatis Medicinalis Anhui
关键词 超声心动图 心力衰竭 左心室功能 阿霉素 echocardiography left ventricular function heart failure doxorubicin
  • 相关文献

参考文献10

二级参考文献57

  • 1王华军,陈金水,陈小明,吴天敏,许昌声,谢良地.阿霉素致大鼠心衰心肌肌球蛋白重链变化[J].中国实验动物学杂志,2001,11(4):202-202. 被引量:2
  • 2苏玲俐,郭瑞强,周青,周立明,郝力丹,陈金玲.应变率显像对高血压患者左室舒张功能的评价[J].中国医学影像技术,2005,21(9):1392-1394. 被引量:12
  • 3Iarussi D,Indolfi P,Casale F,et al. Anthracycline - induced cardiotoxicity in children with eaneer:Strategies for preventlon and man agement[J]. Paediatr Drugs,2005,7:67 - 76.
  • 4Elbl L, Hrstkova H,Chaloupka V. The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer[J]. Eur J Pediatr, 2003,162 : 690 - 696.
  • 5Kalyanaraman B,Joseph J,Kalivendi S,etal. Doxorubicin -induced apoptosis: Implications in cardiotoxicity[J].Mol Cell Biochem, 2002,234 -235:119 - 124.
  • 6Lihe L, Weikang W, Jianyun Y, et al. Adriamycin - induced autophagie cardiomyoeyte death plays a pathogenic role in a rat model of heart failure[J ]. Cardiology, 2009,134 : 82 - 90.
  • 7Ha JW, Kang MS, Pyun BW, et al. Serial assessment of myocardial properties using cyclic variation ot integrated backscatter in an adriamycin- induced cardiomyopathy rat model[J]. Yonsei Medical J,2005,46(1):73 -77.
  • 8Migrino RQ. Aggarwal D, Konorev E, et al. Early detection of doxorubicin cardiomyothy using 2 - dimensional strain echoeardiography[J]. Ultrasound Med Biol,2008,34(2) :208 - 214.
  • 9Brown L, Fenning A, Chan V, et al. Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ, 2002, 11 (3) :167 - 173.
  • 10Sjaastad I, Sejersted OM, Ilebekk A, et al. Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol, 2000,89(4) :1445 - 1454.

共引文献88

同被引文献45

  • 1纪冬琛,李昌煜.病证结合动物模型的制作、评价与展望[J].浙江中医药大学学报,2010,34(4):615-618. 被引量:20
  • 2孙丽敏,金海.阿霉素致心肌损伤及中药对其治疗的研究进展[J].吉林医学,2005,26(11):1233-1235. 被引量:2
  • 3肖刚,王勤.罗汉果研究进展[J].上海中医药杂志,2006,40(11):71-73. 被引量:18
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [ J ]. Circulation, 2005,112 (12) :e154-235.
  • 5Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010 [ J ]. Circulation, 2010, 122 ( 2 ) : 173-183.
  • 6Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association [ J ] . Circulation, 2012, 125 ( 1 ) : e2-e220.
  • 7Ferranti SD, Rifai N. C-reactive protein and cardi- ovascular disease: a review of risk prediction and interventions[J ]. Clin Chin Acta, 2002, 317 (1 -2):1 -15.
  • 8Alonso-Martinez JL, Llorente-Diez B, Echegaray- Agara M, et al. C-reactive protein as a predictor of improvement and readmission in heart failure [J]. Eur J Heart Fail, 2002, 4(3): 331 -336.
  • 9Davila DF, Nunez T J, Odreman R, et al. Mecha- nisms of neurohormonal activation in chronic congestive heart failure: pathophysiology andtherapeutic implications [ J ]. Int J Cardiol, 2005, 101 (3) : 343 -346.
  • 10Kouris NT, Zacharos ID, Kontogianni DD, et al. The significance of CA125 levels in patients with chronic heart failure. Correlation with clinical and echocardiographic parameters [ J ]. Eur J Heat Fail, 2005, 7(2) 199 -203.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部